Global Ophthalmology Drugs and Devices Market, By Devices (Surgical Device, Diagnostics & Monitoring Devices, Vision care) Drug (Glaucoma Drugs, Retinal Disorder Drugs, Dry Eye Drugs, Allergic Conjunctivitis and Inflammation Drugs, Other Drugs), Delivery Type (Capsules & Tablets, Gels, Eye Drops, Eye Ointment, Eye Solutions), End Use (Hospitals, Diagnostic Centres, Others) Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Market Analysis and Insights Global Ophthalmology Drugs and Devices Market
Data Bridge Market Research analyses that the ophthalmology drugs and devices is growing at a CAGR of 5.80% in the forecast period of 2022-2029.
Ophthalmic medical devices is deal with treatment of eye disorder with the laser technology. Drugs are being used to detect certain ocular malformation in the eyes.
The rising number of geriatric population is the major factor accelerating the growth of the market. Furthermore, increasing prevalence of diabetes, increasing investment in research and development, rising eye disorders, presence of strong emerging pipeline drugs are also expected to drive the growth of the ophthalmology drugs and devices. However, lack of health insurance amongst population especially within the developing countries restrains the ophthalmology drugs and devices, whereas, lack of insurance covering all types of IOLs or contact lens in developed countries will challenge the growth of ophthalmology drugs and devices.
In addition, increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration will create ample opportunities for the ophthalmology drugs and devices.
This ophthalmology drugs and devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on ophthalmology drugs and devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Ophthalmology Drugs and Devices Market Scope and Market Size
The ophthalmology drugs and devices market is segmented on the basis of devices, drug, delivery type and end-use. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on devices, market is segmented into surgical devices, diagnostics & monitoring devices and vision care. Diagnostic & monitoring devices are further segmented into optical coherence tomography, ophthalmic ultrasound imaging systems, fundus camera market, ophthalmoscopes, retinoscope, pachymeter, wavefront aberrometers, perimeters/visual field analyzer, autorefractors/phoropter, specular microscope, corneal topographers and other. Surgical devices are further segmented into cataract surgery devices, glaucoma surgery devices, refractive surgery devices and vitreoretinal surgery devices.
- Ophthalmology drugs & devices market has also been segmented based on the drug into glaucoma drugs, retinal disorder drugs, dry eye drugs, allergic conjunctivitis and inflammation drugs and other drugs.
- On the basis of delivery type, ophthalmology drugs & devices market has been segmented into capsules & tablets, gels, eye drops, eye ointment and eye solutions.
- On the basis of end-use, ophthalmology drugs & devices market has been segmented into hospitals, diagnostic centres and others.
Ophthalmology Drugs and Devices Market Country Level Analysis
The ophthalmology drugs and devices market is analysed and market size insights and trends are provided by country, devices, drug, delivery type and end-use as referenced above.
The countries covered in the ophthalmology drugs and devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the ophthalmology drugs and devices market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the large market share of the U.S. in ophthalmology drugs & devices market due to the presence of healthcare facilities and increasing geriatric population in the region. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the rising prevalence of eye disorder and diabetes in the geriatric population.
The country section of the ophthalmology drugs and devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The ophthalmology drugs and devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for ophthalmology drugs and devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the ophthalmology drugs and devices market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Ophthalmology Drugs and Devices Market Share Analysis
The ophthalmology drugs and devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to ophthalmology drugs and devices market.
Some of the major players operating in the ophthalmology drugs and devices market report are Carl Zeiss AG, Novartis AG, Johnson & Johnson Services, Inc., Allergan, Topcon Corporation, NIDEK CO., LTD., HAAG-STREIT GROUP, Ziemer Ophthalmic Systems, Bausch & Lomb Incorporated, Biotech, VisionCare, Inc., Akorn, Incorporated, Bayer AG, Acucela Inc., Regeneron Pharmaceuticals, Inc, Nicox, Santen Pharmaceutical Co., Ltd. and IRIDEX Corporation, among other